Achieve Life Sciences Inc (ACHV)

Achieve Life Sciences Inc (ACHV) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $729M; returns 1 day -0.2%, 1 week +1.7%, 1 year +31.9%.

Achieve Life Sciences Inc (ACHV) is a clinical-stage specialty pharmaceutical company dedicated to developing cytisinicline, a plant-derived alkaloid for smoking cessation and nicotine addiction treatment. The company has no commercial revenue as of January 2026, operating as a pre-commercial biotech funded primarily through equity financings, grants, and partnerships.

Groups ACHV belongs to

• Biotechnology
• Clinical Stage
• Clinical Stage Biotech
• Clinical Stage Biopharma
• Pharmaceuticals
• Healthcare
• Life Sciences
• R&D

ACHV financial model: income statement, cash flow and balance sheet